The latest interleukin: IL-33 the novel IL-1-family member is a potent mast cell activator

Journal of Biological Regulators and Homeostatic Agents

Volumn 23, Issue 1, 2009, Pages 11-14

  Castellani, Maria Luisa ^a   Kempuraj, D J ^b   Salini, V ^a   Vecchiet, J ^a   Tete S ^a   Ciampoli, C ^a   Conti, F ^a   Cerulli, G ^c   Caraffa, A ^c   Antinolfi, P ^c   Theoharides, T C ^b   De Amicis, D ^a   Perrella, A ^d   Cuccurullo, C ^a   Boscolo, P ^a   Shaik, Y ^e  

^a UNIVERSITY OF CHIETI   (Italy)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PERUGIA   (Italy)

^d AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; IL 33; Interleukins; Mast cell

Indexed keywords

CHEMOKINE; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; MONOCYTE CHEMOTACTIC PROTEIN 1;

ALLERGIC DISEASE; AUTOIMMUNITY; CELL ACTIVATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EDITORIAL; EOSINOPHILIA; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATION; MAST CELL; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TH2 CELL;

ANIMALS; ASTHMA; ATHEROSCLEROSIS; INTERLEUKIN-1; INTERLEUKINS; MAST CELLS; MICE;

EID: 64249128283     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (37)

1. Arend WP, Palmer G, Gabay C. IL- 1, IL- 18, and IL-33 families of cytokines. Immunol Rev 2008; 223: 20-38.
2. Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L, Bouche G, Girard JP. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci USA 2007; 104(1):282-7.
3. Cherry WB, Yoon J, Barternes KR, Iijima K, Kita H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol 2008; 121:1484-90.
4. Katsanos GS, Anogianaki A, Castellani ML, et al. Biology of neurotensin: revisited study. Int J Immunopathol Pharmacol 2008; 21:255-9.
5. Floudas CS, Yiakoumis X, Tsironi M, Aessopos A. Reversible normolipemic Xanthelasma palpebrarum associated with inflammation in Castleman's disease. Eur J Inflamm 2008; 6:95-8.
6. Li Q, Morimoto K, Kobayashi M, Inagaki H, et al. A forest bathing trip increases human natural killer activity and expression of anti-cancer proteins in female subjects. J Biol Regul Homeost Agents 2008; 22:45-55.
7. Utsugi M, Ishizuka T, Hisada T, Sato K, Ishizuka T, Dobashi K, Mori M. Hypoxemia with high alveolar-arterial oxygen gradient but no lung involvement in a patient with Churg-Strauss syndrome: case report. Int J Immunopathol Pharmacol 2008; 21:251-3.
8. Inoue K, Takano H, Ohnuki M, Yanagisawa R, Sakurai M, Shimada A, Mizushima K, Yoshikawa T. Size effects of nanornaterials on lung inflammation and coagulatory disturbance. Int J Immunopathol Pharmacol 2008; 21:197-206.
9. Suzukawa M, Iikura M, Koketsu R, et al. An IL- 1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J Immunol 2008; 181:5981-9.
10. Kondo Y, Yoshimoto T, Yasuda K, et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol 2008; 20: 791-800.
11. Theoharides TC, Makris M, Kalogeromitros D. Allergic inflammation and adipocytokines. Int J Immunopathol Pharmacol 2008; 21:1-4.
12. Gelardi M, Maselli Del Giudice A, Fiorella ML, Fiorella R, Russo C, Soleti P, Di Gioacchino M, Ciprandi G. Non-allergic rhinitis with eosinophils and mast cells constitutes a new severe nasal disorder. Int J Immunopathol Pbarmacol 2008; 21: 325-31.
13. Vojdani A, O'Bryan T, Kellermann GH. The immunology of gluten sensitivity beyond the intestinal tract. Eur J Inflamm 2008; 6:49-57.
14. Borrione P, Parisi A, Salvo RA, Spaccamiglio A, Pautasso M, Baraban D, Piccoli GB, Pigozzi F, Angeli A. A peculiar pattern of expression of the transferrin receptor (CD71) by reticulocytes in patients given recombinant human erythropoietin (rHuEPO): a novel marker for abuse in sport? J Biol Regul Homeost Agents 2007; 21:79-88.
15. Sonneck K, Baumgartner C, Rebuzzi L, et al. Recombinant allergens promote expression of aminopeptidase-n (CD13) on basophils in allergic patients Int J Immunopathol Pharmacol 2008; 21: 11-22.
16. Moussion C, Ortega N, Girard J.P. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PUS ONE 2008; 3:3331.
17. Ghoneum. M, Matsuura M, Gollapudi S. Modified arabinoxylan rice bran (mgn-3/biobran) enhances intracellular killing of microbes by human phagocytic cells in vitro. Int J Immunopathol Pharmacol 2008; 21:87-96.
18. Lavagno L, Ferrero E, Ortolan E, Malavasi F, Funaro A. CD157 is part of a supramolecular complex with CD11b/CD18 on the human neutrophil cell surface. J Biol Regul Homeost Agents 2007; 21:5-12.
19. Smithgall MD, Comeau MR, Yoon BRI Kaufman D, Armitage R, Smith DE. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol 2008; 20:1019-30.
20. Di Marzio L, Cinque B, Cupelli F, De Simone C, Cifone MG, Giuliani M. Increase of skin-ceramide levels in aged subjects following a short-term topical application of bacterial sphingomyelinase from Streptococcus thermophilus. Int J Immunopathol Pharrnacol 2008; 21:137-44.
21. Dianzani C, Pierangeli A, Chiricozzi A, Avola A, Degener AM. Cutaneous human papillomaviruses as recurrence factor in actinic keratoses. Int J Immunopathol Pharmacol 2008; 21:145-52.
22. Suzukawa M, Koketsu R, Iikura M, et al. Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils. Lab Invest 2008; 88:1245-53.
23. Riccio A, Postiglione L, Spanào A, Tarantino G. Lack of HCV replication during the course of HCV-associated arthritis. Eur J Inflamm 2008; 6:141-42.
24. Patruno A, Speranza L, Tetè S, et al. iNOS activity in the aged rat liver tissue J Biol Regul Homeost Agents 2007; 21:89-95.
25. Li Q, Morimoto K, Kobayashi M, et al. Visiting a forest, but not a city, increases human natural killer activity and expression of anti-cancer proteins. Int J Immunopathol Pharmacol 2008; 21:117-28.
26. Orciani M, Trubiani O, Cavaletti G, Guarnieri S, Salvolini E, Tredici G, Di Primio R. Expression of CD38 in human neuroblastoma SH-SY5Y cells. Int J Immunopathol Pharmacol 2008; 21:97-106.
27. Kakkar R, Lee RT. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 2008; 7:827-40.
28. Cirillo N, Lanza M, De Rosa A, Femiano F, Gombos F, Lanza A. At least three phosphorylation events induced by pemphigus vulgaris, sera are pathogenically involved in keratinocyte acantholysis. Int J Immunopathol Pharmacol 2008; 21:189-196.
29. Capodicasa E, Cornacchione P, Natalini B, Bartoli A, Coaccioli S, Marconi P, Scaringi L. Omeprazole induces apoptosis in normal human polymorphonuclear leucocytes. Int J Immunopathol Pharmacol 2008; 21:73-86.
30. Hudson CA, Christophi GP, Gruber RC, Wilmore JR, Lawrence DA, Massa PT. Induction of IL-33 expression and activity in central nervous system glia. J Leukoc Biol 2008; 84:631-43.
31. Deepak P, Kumar S, Acharya A. IL- 13 neutralization modulates function of type II polarized macrophages in vivo in a murine T-cell lymphoma. Eur J Inflamm 2007; 5:37-45.
32. Salvolini E, Neri P, Orciani M, Di Primio R, Giovannini A. Intravitreal micronized triamcinolone versus triamcinolone acetonide: a clinical and morphological comparative study. Int J Immunopathol Pharmacol 2008; 21:181-8.
33. Moulin D, Donzé O, Talabot-Ayer D, Mézin F, Palmer G, Gabay C. Interleukin (IL)-33 induces the release of pro-inflarnmatory mediators by mast cells. Cytokine 2007; 40:216-25.
34. Zhang QL, Boscolo P, Niu PY, et al. How do rat cortical cells cultured with aluminum die: necrosis or apoptosis? Int J Immunopathol Pharmacol 2009; 21:107-116.
35. Minardi D, Ghiselli R, Lucarini G, et al. Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation. Int J Immunopathol Pharmacol 2008; 21:129-36.
36. Colanardi MC, Nettis E, Traetta P, Delle Donne P, Ferrannini A, Vacca A. Parecoxib as an alternative in COX-2 hypersensitivity. Int J Immunopathol Pharmacol 2008; 21:233-6.
37. Miller AM, Xu D, Asquith DL, Denby L, Li Y, Sattar N, Baker AH, McInnes 113, Liew FY. IL-33 reduces the development of atherosclerosis. J Exp Med 2008; 205:339-46.